High Prevalence of Bone Related Problems Around the Globe due to Sedentary Lifestyle is Driving Growth of Osteoporosis Drug Market

Osteoporosis Drug market


 Osteoporosis is also referred to the as porous bone. The four main types of osteoporosis drugs are calcium, vitamin D, estrogen, and progestin. These four drugs each have their own mode of action which is usually dependent on the type of mineral that is deficient in a person. Osteoporosis is a bone-related medical condition in which involves the weakening of bones which may lead to a break from fall. 

 The increasing prevalence of osteoporosis around the globe is a prime factor driving the growth of the osteoporosis drug market. Growing geriatric population is another key factor which is the increasing prevalence of the bone-related medical condition. This is again augmenting the demand for osteoporosis drugs. According to the World Health Organization, by 2050, the world's population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015. Continuous launch of novel drug by the key manufacturer in order to cater to rising demand is again projected to foster the growth of the osteoporosis drug market. For instance, in August 2020, Cadila Pharmaceuticals Limited has announced the launch of NuPTH an Osteoporosis biosimilar of Forteo in India. The Forteo biosimilar is used for the treatment of osteoporosis and in patients with increased risk of fracture.

North America is projected to exhibit significant growth over the forecast period and this is attributed to the high prevalence of osteoporosis in the region. According to the U.S. Department of Health and Human Services, osteoporosis affects more women than men. Of the estimated 10 million Americans with osteoporosis, more than 8 million (or 80%) are women. Also, the rise in various research and development activities in the field of osteoporosis therapy is further projected to propel the growth of the osteoporosis drugs market. 

Key Developments:

    1. In April 2019, Amgen and UCB announced that the U.S. Food and Drug Administration (FDA) has approved EVENITY™ (romosozumab-aqqg) for the treatment of osteoporosis in postmenopausal women at high risk for fracture.

    2. In August 2019, Terrosa® produced by Gedeon Richter has been launched in Europe. The drug is approved in adults for the treatment of osteoporosis in postmenopausal women and men at increased risk of fracture as well as for osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture. 

    3. In December 2019, Terumo Corporation announced that a new osteoporosis medication, Teribone™ 28.2㎍ subcutaneous autoinjector, has launched in the Japanese market for patients with a high risk of fractures.

    4. In October 2020, The Italian Medicines Agency (AIFA) has granted approval to conduct human clinical trials on raloxifene, a generic osteoporosis drug to treat paucisymptomatic Covid-19 patients.

Comments

Post a Comment

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Image
  Whiskey or single malt whiskey is simply a form of distilled beverage made by distilling alcohol from grain mash or even by blending both. Different grains are utilized for different types, such as corn, barley, rye, and wheat. In Scotland, they call their whiskey black tea, a lighter caramel scotch, Irish cream, and liqueur. Whichever form is utilized, the result is usually a flavorful and smooth drink that has a distinct taste, and many people prefer a whiskey with a lower alcohol content. For example, single malt whiskey is the least expensive. The highest price however is the least distilled; that is Bourbon whiskey. Bourbon whiskey is the most popular whiskey in America and in many other countries around the world. Its price range is very wide, starting from as low as about US$ 12 a bottle to over a hundred dollars. So the price definitely varies. Whichever class you belong to, there is always a whiskey that will suit your preference. Single malt scotch whiskey is made ...
Read more

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Image
  Viral Vectors are proteins that have been discovered to be essential for the spread of various viruses and infectious agents. These proteins can cause serious health risks if they are improperly introduced or if a wrong agent is used to fight them off. Viral vectors have often been used in various gene therapy procedures with the ultimate objective of curing various ailments in the biological fields of neurology, gene therapy, cancer, and metabolic disorder. Clinical studies regarding viral vectors remain one of the key factors in the manufacturing of viral vectors. Plasmids are used to deliver DNA contain genes for antibiotic resistance. In fact, scientists have developed many uses of plasmids and created software to record the DNA sequences of plasmids for applications in various techniques. Thus, such continuous R&D activities can potentially stimulate growth of the viral vectors and plasmid DNA manufacturing market . Recently, in April 2021, Oxford Biomedica plc entered...
Read more

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)

Image
  There are many reasons why people choose hard surface floors over other types of flooring. Hard surfaces offer a level of durability and are very aesthetically pleasing. Unfortunately, choosing this type of flooring can be confusing and costly. There are four main hard surface varieties namely vinyl plank, laminate, solid hardwood, and engineered wood. Each has their own style strengths and provide different advantages. Increasing population coupled with rapid urbanization is expected to drive growth of the global hard surface flooring market . According to the United Nations (UN), by 2050, around 68% of the global population is expected to live in urban areas, increasing from 55% in 2018. According to the same source, in 2018, around 4.2 billion people were living in urban areas, increasing from 751 million in 1950. Furthermore, according to the World Bank, in 2019, the global population reached 7.674 billion, increasing from 6.84 billion in 2009. As a result of this, building...
Read more